SEC Form 4 · accession 0001209191-16-093116

VERTEX PHARMACEUTICALS INC / MA · VRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jan 20, 2016

Accepted (ET)

Jan 22, 2016 · 4:20 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000875320

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jan 20, 2016	M	10,400	$35.64	A	275,684	D
Common Stock^F2,F3	Jan 20, 2016	S	1,100	$90.46	D	274,584	D
Common Stock^F2,F4	Jan 20, 2016	S	2,200	$91.87	D	272,384	D
Common Stock^F2,F5	Jan 20, 2016	S	2,000	$92.87	D	270,384	D
Common Stock^F2,F6	Jan 20, 2016	S	1,300	$93.71	D	269,084	D
Common Stock^F2,F7	Jan 20, 2016	S	1,900	$95.24	D	267,184	D
Common Stock^F2,F8	Jan 20, 2016	S	800	$96.18	D	266,384	D
Common Stock^F2,F9	Jan 20, 2016	S	1,000	$97.46	D	265,384	D
Common Stock	Jan 20, 2016	S	100	$98.46	D	265,284	D
Common Stock	holding	—	—		—	13,286	I	401k
Common Stock	holding	—	—		—	122,700	I	Common Stock Held In Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F10	$35.64	Jan 20, 2016	M	10,400	D	—	Feb 1, 2016	Common Stock	10,400	11,200	D

F1Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
F10Fully vested.
F2Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3Open market sales reported on this line occurred at a weighted average price of $90.46 (range $90.23 to $90.60).
F4Open market sales reported on this line occurred at a weighted average price of $91.87 (range $91.37 to $92.33).
F5Open market sales reported on this line occurred at a weighted average price of $92.87 (range $92.46 to $93.28).
F6Open market sales reported on this line occurred at a weighted average price of $93.71 (range $93.46 to $93.89).
F7Open market sales reported on this line occurred at a weighted average price of $95.24 (range $94.68 to $95.64).
F8Open market sales reported on this line occurred at a weighted average price of $96.18 (range $95.73 to $96.69).
F9Open market sales reported on this line occurred at a weighted average price of $97.46 (range $97.12 to $97.61).